SCHEMBL28607844

SCHEMBL28607844

CC(C)(C)[Si](Oc1cn(-c2ncncc2Cl)c2ccccc12)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA5 O75582 1/20 0.40
▸ HPGD P15428 4/20 0.36
▸ MAPT P10636 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.33
▸ RECQL P46063 1/20 0.33
▸ LMNA P02545 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GRM4 Q14833 1/20 0.31
▸ MKNK1 Q9BUB5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28606708 0.85 RPS6KA5 (0.40) RPS6KA5HPGDMAPTALDH1A1TDP1
SCHEMBL19100670 0.79 CYP11B1 (0.35) RPS6KA5
SCHEMBL28608545 0.78 HPGD (0.36) RPS6KA5HPGDMAPTALDH1A1TDP1
SCHEMBL28605367 0.77 PIN1 (0.38) HPGDMAPTALDH1A1TDP1NPSR1
SCHEMBL28600554 0.75 RPS6KA5 (0.39) RPS6KA5KDM4EPOLB
SCHEMBL19100385 0.66 RPS6KA5 (0.35) RPS6KA5MKNK1
SCHEMBL31377998 0.63 RPS6KA5 (0.46) RPS6KA5HPGDMAPTALDH1A1TDP1
SCHEMBL15968256 0.62 CHRNB2 (0.34) ALDH1A1TDP1LMNAPOLBKMT2A
SCHEMBL19100706 0.61 CYP11B2 (0.32) MAPTCYP2C9
SCHEMBL1165944 0.61 CYP3A4 (0.41) HPGDMAPTALDH1A1TDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109328059-B Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2021-08-17 — — CN disclosed
CN-109328059-A Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2019-02-12 — — CN disclosed
Send feedback